Home000100 • KRX
add
Yuhan Corp
Previous close
₩113,900.00
Day range
₩113,400.00 - ₩117,800.00
Year range
₩57,142.86 - ₩166,900.00
Market cap
9.81T KRW
Avg Volume
1.94M
P/E ratio
53.23
Dividend yield
0.37%
In the news
Financials
Income Statement
Revenue
Net income
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 598.78B | 23.96% |
Operating expense | 192.76B | 34.67% |
Net income | 37.43B | 91.05% |
Net profit margin | 6.25 | 53.94% |
Earnings per share | 499.00 | 84.49% |
EBITDA | 62.99B | 427.83% |
Effective tax rate | 28.60% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 249.00B | -16.62% |
Total assets | 2.93T | 9.68% |
Total liabilities | 751.18B | 18.20% |
Total equity | 2.17T | — |
Shares outstanding | 75.00M | — |
Price to book | 4.03 | — |
Return on assets | 4.09% | — |
Return on capital | 4.94% | — |
Cash Flow
Net change in cash
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 37.43B | 91.05% |
Cash from operations | -11.81B | -140.91% |
Cash from investing | -50.05B | 15.74% |
Cash from financing | 13.60B | -71.76% |
Net change in cash | -49.20B | -339.91% |
Free cash flow | -83.06B | -75.76% |
About
Yuhan Corporation is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical. Wikipedia
CEO
Founded
1926
Website
Employees
1,994
